Novel and optimized diagnostics for pediatric TB in endemic countries: NOD-pedFEND study protocol
- PMID: 40851094
- PMCID: PMC12376364
- DOI: 10.1186/s12887-025-05554-3
Novel and optimized diagnostics for pediatric TB in endemic countries: NOD-pedFEND study protocol
Abstract
Background: Pediatric tuberculosis is a major global public health challenge, with reliable diagnosis being a main obstacle to identifying and treating affected children. New and improved diagnostics, ideally on non-sputum samples, are urgently required, especially in the most vulnerable group of children under five years of age. Studies to date have been limited by small sample sizes and few bacteriologically-confirmed cases. Here, we describe the study protocol of the NIH-funded NOD-pedFEND study, which will be one of the largest diagnostic studies to date of children at greatest risk of tuberculosis.
Methods: In this prospective observational cohort study, we aim to evaluate existing and novel diagnostic assays, including pathogen- and host-based tests and combinations of tests. A consecutive cohort of children under five years of age with signs and symptoms of tuberculosis is enrolled in Uganda and Peru. All children undergo an extensive baseline workup with signs- and symptoms recording, microbiological reference tests, chest X-ray and tuberculin skin test for rigorous classification according to internationally recognized microbiological, composite reference and strict standards. An array of samples is collected for investigational tests. Follow-up visits are conducted at 2 weeks, 2 months and 6 months. A small cohort of healthy controls is enrolled to evaluate the specificity of selected diagnostics. The study has been approved by the relevant institutional review boards.
Discussion: With this large cohort study of children under five years of age, we aim to make an important contribution to the evaluation of new diagnostics for pediatric tuberculosis. By establishing a comprehensive biorepository, the study will also enable the assessment of novel tests as they become available during and after the study.
Keywords: Assays; Children; Cohort; Diagnosis; Tests; Tuberculosis.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: Local ethical approval has been obtained in Uganda from School of Biomedical Sciences Research Ethics Committee (SBSREC) and Uganda National Counsel for Science and Technology (UNCST) and in Peru from Universidad Peruana Cayetano Heredia Research Ethics Committee (Comité Institucional de Ética en Investigación – Humanos) and the Research Ethics Committees from Hospital Nacional Cayetano Heredia and Hospital Nacional Docente Madre Niño San Bartolomé, and local approval from the National TB program and local registration in PRISA repository (Nº: EI00003204) following local regulations before study commencement. Ethical approval has also been obtained from Rutgers University IRB and the Oxford Tropical Research Ethics Committee. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
Figures
References
-
- Bassyouni H, et al. Childhood tuberculosis: a unified response to a global problem. Int J Tuberc Lung Dis. 2015;19(12):S54–S54. - PubMed
-
- World Health Organization. Global tuberculosis report 2023. [cited 2024 24 April 2024]; Available from: https://www.who.int/publications/i/item/9789240083851.
-
- Marais BJ, et al. Diagnostic and management challenges for childhood tuberculosis in the era of HIV. J Infect Dis. 2007;196(Suppl 1):S76-85. - PubMed
-
- Marais B, et al. The bacteriologic yield in children with intrathoracic tuberculosis. Clin Infect Dis. 2006;42(8):e69–71. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
